An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses-Reference-Cited by-同舟云学术

An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses

Published:2019-08-14 Issue:9 Volume:16 Page:1003-1014
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Longobardi Salvatore¹,Seidler Anke²,Martins Julian³,Beckers Francois⁴,MacGillivray William⁵,D’Hooghe Thomas⁶⁷⁸^ORCID

Affiliation:

1. Global Clinical Development, Merck Serono S.p.A, Rome, Italy

2. Global Strategic Insights, Merck KGaA, Darmstadt, Germany

3. inScience Communications, Springer Healthcare, Paris, France

4. Global Biostatistics, Merck KGaA, Darmstadt, Germany

5. Market Research, Ifop, Paris, France

6. Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany

7. Department of Development and Regeneration, University of Leuven, Leuven, Belgium

8. Department of Obstetrics and Gynecology, Yale University, New Haven, USA

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2019.1651290

Reference20 articles.

1. Understanding the burden of ovarian stimulation: fertility expert and patient perceptions

2. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population

3. Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment

4. Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey

5. Patient evaluation of the redesigned follitropin alfa pen injector

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatment;Expert Opinion on Drug Delivery;2024-02

2. Inadvertent Administration of 72 µg of Follitropin-Δ for Three Consecutive Days Does Not Appear to Be Dangerous for Poor Responders: A Case Series;Journal of Clinical Medicine;2023-08-10

3. Analysis of Nurse and Patient Preferences for Pre-Filled Pen Devices for Self-Injection of Highly Purified Human Menopausal Gonadotropin (HP-hMG, MENOPUR®);Patient Preference and Adherence;2023-05

4. Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models;Best Practice & Research Clinical Obstetrics & Gynaecology;2023-02

5. A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes;Diagnostics;2023-01-04